株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

便秘:パイプライン分析

Constipation - Pipeline Review, H1 2019

発行 Global Markets Direct 商品コード 192536
出版日 ページ情報 英文 100 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.85円で換算しております。
Back to Top
便秘:パイプライン分析 Constipation - Pipeline Review, H1 2019
出版日: 2019年02月01日 ページ情報: 英文 100 Pages
概要

便秘は、排便が困難または頻度が少ない場合に起こります。便秘の症状には腹部の膨張または腹痛、疼痛および嘔吐などがあります。素因には、摂食障害、過敏性腸症候群、甲状腺機能低下症、便秘薬の使い過ぎ、過労、腸筋肉の衰弱、ストレス、水分の摂取不足、食事における繊維の不足などが含まれます。治療には便秘薬の使用と適切なライフスタイルが挙げられます。

当レポートでは、世界における便秘治療薬のパイプラインについて取り上げ、現在の開発パイプラインの状況や最新動向、薬剤プロファイル、主要企業および開発中の製品レビューなどをお届けいたします。

目次

イントロダクション

  • 分析範囲

便秘の概要

治療薬の開発

  • 便秘向けパイプライン製品:概要
  • 便秘向けパイプライン製品:比較分析

便秘:開発中の治療薬 - 企業別

便秘:開発中の治療薬 - 大学・研究機関別

便秘:パイプライン製品の概況

  • 後期段階の製品
  • 臨床段階の製品
  • 初期段階の製品

便秘:開発中の製品 - 企業別

便秘:開発中の製品 - 大学・研究機関別

便秘:治療薬開発に従事している企業

  • AlbireoPharma
  • Ardelyx, Inc.
  • アステラス製薬
  • Braintree Laboratories, Inc.
  • CJ HealthCare Corp.
  • 第一三共
  • Ironwood Pharmaceuticals, Inc.
  • キッセイ薬品工業
  • NGM Biopharmaceuticals, Inc.
  • RaQualia Pharma Inc.
  • Rhythm Pharmaceuticals, Inc.
  • 三和化学研究所
  • Shire Plc
  • SK Biopharmaceuticals Co., Ltd.
  • Sucampo Pharmaceuticals, Inc.
  • 大日本住友製薬
  • Synergy Pharmaceuticals, Inc.
  • Synthetic Biologics, Inc.
  • Yuhan Corporation

便秘:治療薬の評価

  • 単剤治療薬
  • 標的別
  • 作用機序別
  • 投与経路別
  • 分子タイプ別

薬剤プロファイル

  • ASP-7663
    • 製品概要
    • 作用機序
    • R&Dの進捗
  • BLI-400
  • DA-6886
  • DS-3801
  • DSP-6952
  • elobixibat
  • KWA-0711
  • linaclotide
  • lubiprostone
  • NGM-282
  • plecanatide
  • prucalopride succinate
  • relamorelin
  • relenopride hydrochloride
  • RQ-00000010
  • SK-1202
  • 便秘・消化不良治療用5-HT1受容体活性小分子
  • 慢性便秘・過敏性腸症候群治療用 IBAT 阻害剤
  • SYN-010
  • tenapanor hydrochloride
  • Transilon
  • YH-12852

最新のパイプライン動向

休止中のプロジェクト

製品開発マイルストーン

  • 注目のニュース・プレスリリース

付録

図表

図表

List of Tables

  • Number of Products under Development for Constipation, H1 2019
  • Number of Products under Development by Companies, H1 2019
  • Number of Products under Development by Universities/Institutes, H1 2019
  • Products under Development by Companies, H1 2019
  • Products under Development by Universities/Institutes, H1 2019
  • Number of Products by Stage and Target, H1 2019
  • Number of Products by Stage and Mechanism of Action, H1 2019
  • Number of Products by Stage and Route of Administration, H1 2019
  • Number of Products by Stage and Molecule Type, H1 2019
  • Constipation - Pipeline by Allergan Plc, H1 2019
  • Constipation - Pipeline by Ardelyx Inc, H1 2019
  • Constipation - Pipeline by Braintree Laboratories Inc, H1 2019
  • Constipation - Pipeline by Dong-A ST Co Ltd, H1 2019
  • Constipation - Pipeline by Ironwood Pharmaceuticals Inc, H1 2019
  • Constipation - Pipeline by Kissei Pharmaceutical Co Ltd, H1 2019
  • Constipation - Pipeline by MallInckrodt Plc, H1 2019
  • Constipation - Pipeline by NGM Biopharmaceuticals Inc, H1 2019
  • Constipation - Pipeline by RaQualia Pharma Inc, H1 2019
  • Constipation - Pipeline by Sanwa Kagaku Kenkyusho Co Ltd, H1 2019
  • Constipation - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H1 2019
  • Constipation - Pipeline by Synergy Pharmaceuticals Inc, H1 2019
  • Constipation - Pipeline by Synthetic Biologics Inc, H1 2019
  • Constipation - Pipeline by Vanda Pharmaceuticals Inc, H1 2019
  • Constipation - Pipeline by Yuhan Corp, H1 2019
  • Constipation - Pipeline by Zensun (Shanghai) Sci & Tech Co Ltd, H1 2019
  • Constipation - Dormant Projects, H1 2019
  • Constipation - Discontinued Products, H1 2019

List of Figures

  • Number of Products under Development for Constipation, H1 2019
  • Number of Products under Development by Companies, H1 2019
  • Number of Products by Top 10 Targets, H1 2019
  • Number of Products by Stage and Top 10 Targets, H1 2019
  • Number of Products by Top 10 Mechanism of Actions, H1 2019
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019
  • Number of Products by Routes of Administration, H1 2019
  • Number of Products by Stage and Routes of Administration, H1 2019
  • Number of Products by Molecule Types, H1 2019
  • Number of Products by Stage and Molecule Types, H1 2019
目次
Product Code: GMDHC11054IDB

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Constipation - Pipeline Review, H1 2019, provides an overview of the Constipation (Gastrointestinal) pipeline landscape.

Constipation refers to the infrequent or difficult passing of stool. Constipation occurs when bowel movements become difficult or less frequent. Symptoms of constipation include swollen abdomen or abdominal pain, pain and vomiting. The predisposing factors include eating disorders, irritable bowel syndrome, and hypothyroidism, overuse of laxatives (stool softeners) which, over time, weaken the bowel muscles, stress, inadequate water intake and inadequate fiber in the diet. Treatment includes use of laxatives and proper lifestyle.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Constipation - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Constipation (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Constipation (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Constipation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 2, 8, 2, 4, 1 and 1 respectively. Similarly, the Universities portfolio in Discovery stages comprises 1 molecules, respectively.

Constipation (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Constipation (Gastrointestinal).
  • The pipeline guide reviews pipeline therapeutics for Constipation (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Constipation (Gastrointestinal) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Constipation (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Constipation (Gastrointestinal)

Reasons to buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Constipation (Gastrointestinal).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Constipation (Gastrointestinal) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

  • Introduction
  • Constipation - Overview
  • Constipation - Therapeutics Development
  • Constipation - Therapeutics Assessment
  • Constipation - Companies Involved in Therapeutics Development
  • Constipation - Drug Profiles
  • Constipation - Dormant Projects
  • Constipation - Discontinued Products
  • Constipation - Product Development Milestones
  • Appendix
Back to Top